Skip to main content
Sintilimab plus IBI305: A promising treatment option for advanced HCC
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Sintilimab plus IBI305: A promising treatment option for advanced HCC
User login
Username
Password
Reset your password
Concept
Lead
score
Hepatocellular Carcinoma
1
1
Biologic Therapy
0
1
Cancer
0
0.78
Angiogenesis Inhibitors
0
0.52
Biosimilars
0
0.52
Humanized Monoclonal Antibody
0
0.52
Clinical Research
0
0.26
Tumor
0
0.26
Healthcare and Medical Technology
0
0.21
Specialty
Lead
score
Hematology-Oncology
1
1
Gastroenterology
0
1
Pharmacist
0
1
Edit Tags